11月25日，永和流体智控股份有限公司（简称"永和智控"）公告，公开挂牌转让全资孙公司昆明医科肿 瘤医院有限公司（简称"昆明医科"）100%股权的申请已获西南联合产权交易所受理。这意味着，永和 智控投资的4家民营肿瘤医院将被全部"清仓"，这家以水暖阀门管件起家的制造企业，正式宣告全面退 出医疗行业。 三折"甩卖"昆明医科 11月18日，永和智控发布公告，拟在产权交易所公开挂牌转让全资孙公司昆明医科100%股权，首次挂 牌底价不低于3592.77万元。交易完成后，永和智控将不再持有昆明医科股权，昆明医科不再纳入公司 合并报表范围。 公告显示，昆明医科的经营状况并不理想。2025年1-7月，昆明医科实现营业收入1157.78万元，净利润 为-659.48万元；2024年亏损496.75万元。这样的业绩表现，或许是永和智控急于抛售的原因之一。 此后，其业绩急转直下。近年来，一直处于亏损状态。2022年至2024年，永和智控营业收入分别为9.90 亿元、9.48亿元和8.23亿元，同比分别增长-1.86%、-4.19%和-13.19%；归母净利润分别为-2618.67万 元、-1.56亿元和-2.97亿元，同比分别下 ...

Core Viewpoint - Yonghe Intelligent Control is facing significant challenges in asset divestiture and ongoing financial losses, indicating a deteriorating business situation and lack of investor interest in its assets [1][2][3]. Group 1: Asset Transfer Attempts - Yonghe Intelligent Control announced the public transfer of 51% equity in Taixing Pule and all debts owed by Taixing Pule, with an initial listing price of RMB 30.49 million, but failed to attract any interested buyers [1][3]. - Following the lack of interest, the company plans a second round of asset transfer at a reduced price of RMB 24.39 million, reflecting a 20% decrease from the initial price [1][3]. - The company's previous attempt to transfer shares held by its actual controller was also unsuccessful, as the buyer failed to make the required payment, rendering the agreement void [1][9]. Group 2: Financial Performance - Yonghe Intelligent Control has experienced a continuous decline in revenue since 2022, with reported revenues of RMB 9.90 billion, RMB 9.48 billion, and RMB 8.23 billion for the years 2022, 2023, and 2024 respectively, showing year-on-year declines of -1.86%, -4.19%, and -13.19% [2][7]. - The company reported net losses of RMB 261.87 million, RMB 1.56 billion, and RMB 2.97 billion for the same years, with losses increasing significantly year-on-year [2][7]. - For the first three quarters of 2025, Yonghe Intelligent Control reported revenues of RMB 5.82 billion, a decrease of 7.25% year-on-year, and a net loss of RMB 60.46 million, although this loss was less than the previous year's figure [8]. Group 3: Company Background and Business Operations - Yonghe Intelligent Control's main business includes water and heating valve fittings, tumor precision radiation treatment, and photovoltaic cell operations, with a focus on brass and copper products [7]. - The company acquired a 51% stake in Taixing Pule in late 2022 for RMB 31.22 million, aiming to enter the photovoltaic cell industry, but has since struggled with the performance of this investment [5][8]. - As of May 31, 2025, Taixing Pule reported a net asset value of -RMB 304 million and a debt of RMB 185 million, leading to a high debt-to-asset ratio of 211% [4].